Editorial Policies

Focus and Scope

Current Oncology is a peer-reviewed, Canadian-based and internationally respected journal. Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy in Canada to report upon and to review progress in the management of this disease.

We encourage submissions from all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. For a complete list of article areas that we publish, please visit http://www.current-oncology.com/index.php/oncology/about/submissions#JournalSections. Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.

Benefits of Publishing with Current Oncology include:

  • Articles are freely and permanently accessible online immediately upon publication
  • Distributed in print gratis to the Canadian oncology community
  • Published articles are sent to and immediately available in PubMed Central (PMC)
  • Impact factor of 1.829, as published in the 2016 Journal Citation Reports, Science Edition
  • Is covered by the following major indexing services:
    • PubMed/PubMed Central
    • Embase
    • Science Citation Index Expanded (SciSearch)
    • Journal Citation Reports/Science Edition
    • EBSCOhost.com Research Databases
    • CrossRef
    • DOAJ (Directory of Open Access Journals)
    • Index Copernicus
    • Scopus
  • Published manuscripts will be invited to participate in the Cancer Knowledge Network, Current Oncology’s interactive dialogue Web site
  • Authors are granted specific rights for a large number of author uses

 

Section Policies

Editorial

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Commentary

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Cancer Narratives: Words Beyond Disease

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Biomarkers in Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Biomedical Ethics

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Bone and Soft Tissue Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cancer Control and Prevention

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cancer Genetics

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cancer Rehabilitation and Survivorship

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Geriatric Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Immuno-Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Clinical Trials

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Integrative Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Knowledge Translation

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Medical Economics

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Medical Legal

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Medical Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Nursing

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Nutrition

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Oncofertility

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Oncologic Pathology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Oncology Education

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Palliative Care

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Pediatric Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Psychosocial Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Radiation Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Surgical Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Translational Research

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Urologic Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Review Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Practice Guideline

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Perspectives in Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Short Communication

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case Report

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Meeting Report

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Letter to the Editor

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed
 

Peer Review Process

All manuscripts are initially reviewed by the editorial staff, and if appropriate, will be assigned to a section editor. If the paper is judged to be suitable for possible publication, it will be sent to two or more external reviewers using our database of experts. All articles undergo this process with the following exceptions, which do not undergo our standard review process:

  • Letters to the Editor, Commentaries and Editorials are based on the decision of the Editor, who may ask experts on the merit of their contents.
  • Practices Guidelines/Consensus Statements - Special considerations may be made in this case as they are typically authored by experts in the field. The authors of the manuscript are asked to sign a form stating they have approved the manuscript and it is acceptable for publication. If they choose not to sign this, they must provide a list of five potential reviewers to review the manuscript, and the article will go through our standard peer review process. The Editors reserve the right to choose all reviewers and may not necessarily select reviewers from the list provided.
  • Meeting Reports – based on the decision of the Editor.
  • Special Articles – depending on the format and content, special articles may be solely based on the decision of the Editor, or undergo our standard review process.

At time of submission, authors are requested to provide at least three potential reviewers (name, affiliation and email address), who could, in their opinion, expertly review their manuscripts. The Editors, however, reserve the right to choose all reviewers. These reviewers should not have published with any of the co-authors during the past five years and should not currently work or collaborate with one of the institutes of the co-authors of the submitted manuscript.

Current Oncology employs a single-blind review process. The identities of the reviewers are kept confidential, but the identity of the author or authors is made known to the reviewers. The manuscript under review is not revealed to anyone other than the reviewers and editorial staff. Reviewers are required to maintain confidentiality about the manuscripts they review. Authors should expect to receive an initial decision on their manuscript within 2–6 weeks of submission. If revision of the manuscript is required, the authors must submit within three weeks of the request.

 

Publication Frequency

Current Oncology is published bi-monthly (six times per year) in the following months; February, April, June, August, October, December. We also publish special supplemental issues, which vary in frequency from year to year.

 

Open Access Policy

Beginning with the December 2005 issue of Current Oncology, Multimed Inc. has provided open access to all articles on our website at www.current-oncology.com. Immediately upon publication, all articles are freely available and searchable for all users.

For the journal Current Oncology, open access means:

  • peer-reviewed literature is freely available online without subscription or price barriers, and
  • literature is immediately released in open access format (no embargo period)

 

Archiving

Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC), the U.S. National Library of Medicine's digital archive of biomedical and life sciences journal literature.

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...

 

Indexing

Current Oncology is indexed/covered in PubMed, EMBASE (Excerpta Medica Database), Scopus, Journal Selector, CrossRef, Index Copernicus, DOAJ (Directory of Open Access Journals), Google Scholar, EMCare, EBSCOhost.com Research Databases, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition. Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC), the U.S. National Library of Medicine's digital archive of biomedical and life sciences journal literature. It is also available in the databases of 100 libraries worldwide, and is a participant of the HINARI program.

 

Online Advertising Policy

Current Oncology accepts advertising and sponsorship for its website and e-mail service according to the following principles:

  1. All advertisements are subject to approval of Current Oncology, which reserves the right to reject or cancel any advertisement at any time.
  2. Current Oncology’s advertising sales representatives have neither control over, nor prior knowledge of, specific editorial content before it is published.
  3. Advertisers have no control or influence over the results of searches a user may conduct on the Current Oncology website. Search results are based solely on the functionality available through our search software (e.g., keywords or natural language) and user-defined criteria (e.g., displaying most recent or most relevant items first).
  4. Current Oncology does not release personally identifiable data on the users of our websites or e-mail service to advertisers.
  5. Online advertisers may receive reports that show aggregated data about response to their advertisements, including the number of ad impressions and the number of times an advertisement was clicked on.
  6. Advertiser links to other websites cannot prevent a user from easily returning to the Current Oncology website.
  7. Alcoholic beverages and tobacco products will not be advertised.
  8. Advertisements may not include offers for free merchandise or contests.
  9. All advertisements must be clearly germane to the practice of medicine.
  10. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
  11. Advertising that appears on the Current Oncology website must be clearly distinguishable from editorial content.
  12. Advertising copy must be factual and in good taste.
  13. All advertisements are accepted and published by Current Oncology on the warranty of the agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
  14. In consideration of publication of an advertisement, the advertiser and the agency, jointly and severally, agree to indemnify and hold harmless Current Oncology, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
  15. Any advertising for the promotion of Current Oncology and the Current Oncology website will be clearly identified and point only to the feature advertised.

Policy on Recruitment Advertisements

  1. All advertisements for employment must be nondiscriminatory and comply with all applicable laws and regulations. Ads that discriminate against applicants based on sex, age, race, religion, marital status, or physical handicap will not be accepted.
  2. International recruitment advertisers are required to confirm in writing that they are an equal opportunity employer.

Current Oncology’s Online Advertising Policy and Types of Advertising Generally acceptable for consideration
Pharmaceutical products; medical-equipment products and services; medical software; practice-management products and services (including office equipment and supplies, medical billing systems, medical software products) and medical web sites.

Generally acceptable for consideration with certain conditions
Calls for patients to participate in clinical trials, or clinical-trial matching services: considered solely if the trial is conducted by a recognized academic institution.
All types of advertising not described above will be reviewed on a case-by-case basis.
Advertisers, media buyers, and others with specific questions about advertising acceptability should contact 905-975-2456 or email current_oncology@multi-med.com